Skip to main content
Clinical Trials/EUCTR2015-000162-59-FR
EUCTR2015-000162-59-FRActive, not recruitingPhase 1

Evaluation of botulinum toxin injection efficacy in the treatment of head essential tremor by a multi-center, randomized, double–blind, parallel-group, placebo-controlled study - Btx-HT

CHU Clermont-Ferrand0 sites120 target enrollmentStarted: June 3, 2015Last updated:
Drugs

Trial Snapshot

Phase
Phase 1
Status
Active, not recruiting
Sponsor
Enrollment
120

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional clinical trial of medicinal product

Eligibility Criteria

Sex
All

Inclusion Criteria

  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range
  • F.1.3 Elderly (>=65 years) yes
  • F.1.3.1 Number of subjects for this age range

Exclusion Criteria

  • Not provided

Investigators

Sponsor
CHU Clermont-Ferrand

Similar Trials